Grand Pharmaceutical Group Investor Relations Material
Latest events
H2 2024
19 Mar, 2025
H1 2024
19 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Grand Pharmaceutical Group Limited
Access all reports
Grand Pharmaceutical Group Limited is a healthcare company engaged in the research, development, manufacturing, and distribution of pharmaceutical and medical products. The company specializes in prescription drugs, biopharmaceuticals, medical devices, and consumer healthcare products, serving therapeutic areas such as cardiovascular, respiratory, oncology, and ophthalmology. The company is headquartered in Wuhan, China, and its shares are listed on the Hong Kong Stock Exchange (HKEX).
Latest articles
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
Ticker symbol
512
Country
🇭🇰 Hong Kong